Vyvanse Drug Approved Today By FDA For Binge Eating Disorder

January 31, 2015 12:50 AM

3 0

Today The U.S. Food and Drug Administration approved Shire Plc’s stimulant Vyvanse to treat binge-eating disorder, the first product to be approved for the wide-spread condition.

Vyvanse, which is currently approved to treat attention deficit hyperactivity disorder, generated sales of more than $1 billion in the first nine months of 2014.

Read more

To category page